Literature DB >> 14648632

Mechanistic study of the uptake of wheat germ agglutinin-conjugated PLGA nanoparticles by A549 cells.

Yun Mo1, Lee-Yong Lim.   

Abstract

The purpose of this study was to evaluate the extent and mechanism of uptake of wheat germ agglutinin-conjugated PLGA nanoparticles by A549 cells. PLGA nanoparticles of 150 nm were prepared by a solvent diffusion method and covalently conjugated to FITC-WGA (fWGA) or FITC-bovine serum albumin (fBSA) by a two-step carbodiimide method. Uptake of fWGA-PLGA and fBSA-PLGA nanoparticles by confluent A549 cells was quantified by fluorometry. A549 cellular uptake of fWGA-PLGA nanoparticles at 2 h, 37 degrees C was 5.02-fold that of fBSA-PLGA nanoparticles at a loading concentration of 2.65 mg/mL. The difference in uptake between the two types of nanoparticles was increased to 7.84-fold at a higher loading concentration of 5.3 mg/mL, but was reduced to 2.07-fold by lowering the uptake temperature to 4 degrees C. Coincubation with 5 mg/mL of unlabeled WGA negated the differential uptake of fWGA-PLGA nanoparticles at 4 degrees C, suggesting that the nanoparticles interacted with a specific WGA-binding receptor on the cell membrane. Internalization of the fWGA-PLGA nanoparticles by the A549 cells was confirmed by confocal microscopy. Filipin (1 microg/mL), a known inhibitor of caveolae, reduced the 1-h uptake of the nanoparticles by 75%. Surface modification of PLGA nanoparticles with WGA significantly enhanced its endocytosis by A549 cells by a receptor-mediated, caveola-dependent pathway. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14648632     DOI: 10.1002/jps.10507

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  Self-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxel.

Authors:  Jingwei Xie; Chi-Hwa Wang
Journal:  Pharm Res       Date:  2005-09-03       Impact factor: 4.200

2.  Wheat Germ Agglutinin-Conjugated Disulfide Cross-Linked Alginate Nanoparticles as a Docetaxel Carrier for Colon Cancer Therapy.

Authors:  Hock Ing Chiu; Vuanghao Lim
Journal:  Int J Nanomedicine       Date:  2021-04-22

Review 3.  Role of Physicochemical Properties in Nanoparticle Toxicity.

Authors:  Seung Won Shin; In Hyun Song; Soong Ho Um
Journal:  Nanomaterials (Basel)       Date:  2015-08-19       Impact factor: 5.076

Review 4.  Biomimetic strategies for targeted nanoparticle delivery.

Authors:  Diana Dehaini; Ronnie H Fang; Liangfang Zhang
Journal:  Bioeng Transl Med       Date:  2016-05-27

5.  The Two Sweet Sides of Janus Lectin Drive Crosslinking of Liposomes to Cancer Cells and Material Uptake.

Authors:  Lina Siukstaite; Francesca Rosato; Anna Mitrovic; Peter Fritz Müller; Katharina Kraus; Simona Notova; Anne Imberty; Winfried Römer
Journal:  Toxins (Basel)       Date:  2021-11-09       Impact factor: 4.546

6.  The impact of calcium phosphate on FITC-BSA loading of sonochemically prepared PLGA nanoparticles for inner ear drug delivery elucidated by two different fluorimetric quantification methods.

Authors:  Julia Clara Gausterer; Clara Schüßler; Franz Gabor
Journal:  Ultrason Sonochem       Date:  2021-10-09       Impact factor: 7.491

Review 7.  Recent advancements in enzyme-incorporated nanomaterials: Synthesis, mechanistic formation, and applications.

Authors:  Shamini Anboo; Sie Yon Lau; Jibrail Kansedo; Pow-Seng Yap; Tony Hadibarata; Jaison Jeevanandam; Azlina H Kamaruddin
Journal:  Biotechnol Bioeng       Date:  2022-07-29       Impact factor: 4.395

Review 8.  Concepts and practices used to develop functional PLGA-based nanoparticulate systems.

Authors:  Hongkee Sah; Laura A Thoma; Hari R Desu; Edel Sah; George C Wood
Journal:  Int J Nanomedicine       Date:  2013-02-21

9.  Docetaxel-Loaded Disulfide Cross-Linked Nanoparticles Derived from Thiolated Sodium Alginate for Colon Cancer Drug Delivery.

Authors:  Hock Ing Chiu; Asila Dinie Ayub; Siti Nur Aishah Mat Yusuf; Noorfatimah Yahaya; Erazuliana Abbd Kadir; Vuanghao Lim
Journal:  Pharmaceutics       Date:  2020-01-02       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.